Performance of 18F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer

Performance of 18F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer

ObjectiveTo assess the performance of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) radiomics features for predicting EGFR mutation status in patients with non-small cell lung cancer (NSCLC).Patients and MethodsWe enrolled total 173 patients wi...

Full description

Bibliographic Details
Main Authors: Min Zhang, Yiming Bao, Weiwei Rui, Chengfang Shangguan, Jiajun Liu, Jianwei Xu, Xiaozhu Lin, Miao Zhang, Xinyun Huang, Yilei Zhou, Qian Qu, Hongping Meng, Dahong Qian, Biao Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
positron emission tomography/computed tomography
radiomics
lung cancer
epidermal growth factor receptor
18F-fluorodeoxyglucose
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.568857/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.568857/full

Similar Items